| Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma K Supimon, T Sangsuwannukul, J Sujjitjoon, N Phanthaphol, ... Scientific reports 11 (1), 6276, 2021 | 41 | 2021 |
| Aberrant mRNA splicing of paired box 4 (PAX4) IVS7-1G>A mutation causing maturity-onset diabetes of the young, type 9 J Sujjitjoon, S Kooptiwut, N Chongjaroen, W Tangjittipokin, N Plengvidhya, ... Acta diabetologica 53, 205-216, 2016 | 39 | 2016 |
| Defective PAX4 R192H transcriptional repressor activities associated with maturity onset diabetes of the young and early onset-age of type 2 diabetes S Kooptiwut, N Plengvidhya, T Chukijrungroat, J Sujjitjoon, N Semprasert, ... Journal of Diabetes and its Complications 26 (4), 343-347, 2012 | 36 | 2012 |
| Fourth-generation chimeric antigen receptor T cells targeting folate receptor alpha antigen expressed on breast cancer cells for adoptive T cell therapy P Luangwattananun, M Junking, J Sujjitjoon, Y Wutti-In, N Poungvarin, ... Breast Cancer Research and Treatment 186, 25-36, 2021 | 32 | 2021 |
| Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells T Sangsuwannukul, K Supimon, J Sujjitjoon, N Phanthaphol, ... International Immunopharmacology 89, 107069, 2020 | 31 | 2020 |
| Chimeric antigen receptor T cells targeting integrin αvβ6 expressed on cholangiocarcinoma cells N Phanthaphol, C Somboonpatarakun, K Suwanchiwasiri, ... Frontiers in oncology 11, 657868, 2021 | 27 | 2021 |
| Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells A Panya, C Thepmalee, N Sawasdee, J Sujjitjoon, N Phanthaphol, ... Cancer Immunology, Immunotherapy 67, 1579-1588, 2018 | 26 | 2018 |
| PAX4 R192H and P321H polymorphisms in type 2 diabetes and their functional defects J Sujjitjoon, S Kooptiwut, N Chongjaroen, N Semprasert, W Hanchang, ... Journal of human genetics 61 (11), 943-949, 2016 | 25 | 2016 |
| GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma–assessing tumor and T cell interaction J Sujjitjoon, E Sayour, ST Tsao, M Uiprasertkul, K Sanpakit, ... Translational oncology 14 (2), 100971, 2021 | 24 | 2021 |
| Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells N Sawasdee, C Thepmalee, J Sujjitjoon, P Yongpitakwattana, M Junking, ... International Immunopharmacology 78, 106006, 2020 | 23 | 2020 |
| Novel adiponectin variants identified in type 2 diabetic patients reveal multimerization and secretion defects P Jungtrakoon, N Plengvidhya, W Tangjittipokin, S Chimnaronk, ... PloS one 6 (10), e26792, 2011 | 23 | 2011 |
| Estradiol prevents high glucose-induced β-cell apoptosis by decreased BTG2 expression S Kooptiwut, S Kaewin, N Semprasert, J Sujjitjoon, M Junking, K Suksri, ... Scientific reports 8 (1), 12256, 2018 | 21 | 2018 |
| Development of a novel anti-CD19 CAR containing a fully human scFv and three costimulatory domains Y Wutti-In, J Sujjitjoon, N Sawasdee, A Panya, K Kongkla, P Yuti, ... Frontiers in Oncology 11, 802876, 2022 | 15 | 2022 |
| Suppression of TGF-β and IL-10 receptors on self-differentiated dendritic cells by short-hairpin RNAs enhanced activation of effector T-cells against cholangiocarcinoma cells C Thepmalee, A Panya, J Sujjitjoon, N Sawasdee, N Poungvarin, ... Human Vaccines & Immunotherapeutics 16 (10), 2318-2327, 2020 | 15 | 2020 |
| Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells M Wathikthinnakon, P Luangwattananun, N Sawasdee, C Chiawpanit, ... Scientific Reports 12 (1), 6154, 2022 | 14 | 2022 |
| Molecular genetics of monogenetic beta-cell diabetes J Sujjitjoon, P Jungtrakoon, W Boonyasrisawat, N Chongjaroen, ... Genomics and Genetics 1 (2), 93-108, 2008 | 8 | 2008 |
| DNAJC3 mutation in Thai familial type 2 diabetes mellitus S Kulanuwat, W Tangjittipokin, P Jungtrakoon, C Chanprasert, J Sujjitjoon, ... International Journal of Molecular Medicine 42 (2), 1064-1073, 2018 | 7 | 2018 |
| Cytotoxic activity of anti-mucin 1 chimeric antigen receptor T cells expressing PD-1-CD28 switch receptor against cholangiocarcinoma cells K Supimon, T Sangsuwannukul, J Sujjitjoon, T Chieochansin, M Junking, ... Cytotherapy 25 (2), 148-161, 2023 | 5 | 2023 |
| Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition P Yuti, Y Wutti-In, N Sawasdee, K Kongkhla, N Phanthaphol, K Choomee, ... International Immunopharmacology 113, 109442, 2022 | 5 | 2022 |
| GD2-specific chimeric antigen receptor T cells targeting retinoblastoma J Sujjitjoon, LS Atchaneeyasakul, ST Tsao, E Sayour, P Yenchitsomanus, ... Cancer Research 75 (15_Supplement), 3150-3150, 2015 | 5 | 2015 |
